Amrittej Virk
Orofacial Pain · Southlake, TXNPI 1346732153
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,139 of the $3,339 with a category attached, or 64.1%. 7 manufacturers reported payments, led by Biohaven Pharmaceutical Holding Company Ltd. at 50.4% of the total. Reporting peaked in 2022 at $1,765 and has fallen 81.6% since, to $325 in 2025.
Across 107 payments — averaging $31.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Pfizer$734
- AbbVie$558
- Biohaven Pharmaceuticals, Inc.$182
- Dentsply Sirona Inc$148
- Patterson Companies, Inc.$18
- plus $15 from 1 others
What the payments were for
- Consulting fees$1,20036%
- Food & beverage$2,13964%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 32 | $1,683 |
| Pfizer | 45 | $734 |
| AbbVie(2 entities) | 20 | $558 |
| Biohaven Pharmaceuticals, Inc. | 4 | $182 |
| Dentsply Sirona Inc | 4 | $148 |
| Patterson Companies, Inc. | 1 | $18 |
| Somnomed Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,305
- QULIPTA$125
- ZAVZPRET$108
How this compares
Too few orofacial pain providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $311 |
| Baclofen | 12 | $245 |
| Amitriptyline Hcl | 13 | $144 |
Paid to pharmacies, not to this prescriber.
Other orofacial pain in Southlake
- Azusa KuwashimaSouthlake$353
- Erkan OnurluSouthlake$160
- Sam WiseRockwall$8K
- Andrew DrollingerHouston$3K
- Steven BenderDallas$409
- Andres Martinez PorrasHouston$321
- Veena KantiPlano$183
- Hazha PashaCypress$143
- Thomas WeberJbsa Lackland$73
- Haba AbdullahAbilene$50
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.